Table 3.

Independent associations of clinical and demographic characteristics with CAP and LS*

	CAP difference (dB/m) (95% CI)†	P value	LS % change (95% CI)‡	P value
Infection status (ref=HIV−/HCV−)
HIV+/HCV−	1.1 (−5.3 to 7.5)	0.74	4.4% (−1.1% to 10.3%)	0.12
HIV+/HCV+	−9.2 (−18.2 to –0.3)	0.04	33.4% (23.5% to 44.1%)	<0.001
HIV−/HCV+	−10.4 (−23.8 to 3.1)	0.13	43.2% (27.8% to 60.4%)	<0.001
Age (per 10 years)	2.4 (−2.0 to 6.9)	0.29	4.4% (0.4% to 8.4%)	0.03
Race/Ethnicity (ref=white non-Hispanic)
Black	−6.1 (−14.2 to 2.1)	0.14	2.8% (−4.0% to 10.1%)	0.43
Hispanic	−3.1 (−12.6 to 6.4)	0.52	3.1% (−5.0% to 11.7%)	0.47
Other	2.9 (−8.2 to 14.0)	0.61	2.5% (−6.7% to 12.7%)	0.60
Waist circumference (per 10 cm)	17.8 (16.2 to 19.4)	<0.001	5.0% (3.3% to 6.6%)	<0.001
HOMA-IR (per doubling)	1.2 (0.8 to 1.6)	<0.001	0.3% (−0.1% to 0.7%)	0.11
CAP (per 10 dB/m)			0.6% (0.1% to 1.0%)	0.01

*All variables shown in the table are included in a single multiple linear regression model (one model for CAP and one for LS). Also adjusted for alcohol use, smoking status and menopause stage (parameter estimates not shown).

†N=1543.

‡N=1576.

CAP, controlled attenuation parameter; HCV, hepatitis C virus; HOMA-IR, homeostatic model assessment of insulin resistance; LS, liver stiffness.